NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.
All applications that require moderately sensitive measurement of estradiol:
-Evaluation of hypogonadism and oligo-amenorrhea in females
-Assessing ovarian status, including follicle development, for assisted reproduction protocols (eg, in vitro fertilization)
-In conjunction with lutenizing hormone measurements, monitoring of estrogen replacement therapy in hypogonadal premenopausal women
-Evaluation of feminization, including gynecomastia, in males
-Diagnosis of estrogen-producing neoplasms in males, and, to a lesser degree, females
-As part of the diagnosis and work-up of precocious and delayed puberty in females, and, to a lesser degree, males
-As part of the diagnosis and work-up of suspected disorders of sex steroid metabolism, eg, aromatase deficiency and 17 alpha-hydroxylase deficiency
-As an adjunct to clinical assessment, imaging studies and bone mineral density measurement in the fracture risk assessment of postmenopausal women, and, to a lesser degree, older men
-Monitoring low-dose female hormone replacement therapy in post-menopausal women
-Monitoring antiestrogen therapy (eg, aromatase inhibitor therapy)
Testing Algorithm Delineates situation(s) when tests are added to the initial order. This includes reflex and additional tests.
See Steroid Pathways in Special Instructions.
Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
17- Beta Estradiol